CENGİZ SEVAL, G. Et Al. 2020. Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML). BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1 , 192-193.

CENGİZ SEVAL, G., Ulas, E. B., TOPRAK, S. K., CİVRİZ BOZDAĞ, S., Yuksel, M. K., TOPÇUOĞLU, P., ... DALVA, K.(2020). Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML). BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, 192-193.

CENGİZ SEVAL, GÜLDANE Et Al. "Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML)," BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, 192-193, 2020

CENGİZ SEVAL, GÜLDANE C. Et Al. "Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML)." BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, pp.192-193, 2020

CENGİZ SEVAL, G. Et Al. (2020) . "Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML)." BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, pp.192-193.

@article{article, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML)}, journal={BONE MARROW TRANSPLANTATION}, year=2020, pages={192-193} }